FidoCure

FidoCure® uses genomic testing to identify possible cancer-causing mutations and then suggests targeted therapy to precisely attack the cancer cells. With FidoCure®, dogs with cancer receive access to the latest scientific advances in cancer care, from tests to treatment.

58.9logo
logo
logo
logo
logo
logo
58.9
logo
NaN
logo
NaN
logo
NaN
logo
NaN
Links
logologologologologo
Valuation
logo
$
Valuation
Funding
logo
$
$ 10.00 M
$ 10.00 M
Funding
$ 10.00 M
$ 10.00 M
Statistics
logo
NA
Action

FidoCure® uses genomic testing to identify possible cancer-causing mutations and then suggests targeted therapy to precisely attack the cancer cells. With FidoCure®, dogs with cancer receive access to the latest scientific advances in cancer care, from tests to treatment.

0and0